The US Food and Drug Administration is leaning toward authorizing half-dose booster shots of the Moderna Inc. coronavirus vaccine, satisfied that it’s effective in shoring up protection, people familiar with the matter said.
For more coronavirus news, visit our dedicated page.
The authorization would set the stage to further widen the US booster campaign after earlier authorization of the Pfizer Inc.-BioNTech SE shot. About 170 million fully vaccinated people in the US received the Moderna or Pfizer shots, or 92 percent of the total inoculated so far.
The people spoke on the condition of anonymity, before a potential announcement. It’s not clear when an announcement will come.
Any authorization would also introduce different dosage levels for boosters. Moderna’s initial inoculations contained 100-microgram doses, and the company’s submission to regulators amounted to a push to authorize a half-dose booster, which would allow Moderna to produce more. Pfizer’s shot, for comparison, has 30-microgram initial doses and a 30-microgram booster.
Moderna declined to comment on Tuesday night. The White House and the FDA declined to comment.
The US is rolling out boosters to head off what President Joe Biden’s health advisers warn are a pair of concerning trends: Hints that vaccine efficacy wanes over months, and that the two-dose regiments are weaker generally against the delta variant. The US has dealt with a summer and fall wave of new cases, hospitalizations and deaths, driven by spread among unvaccinated people but increasing the exposure risk for the vaccinated.
The FDA had been seeking information about the effectiveness of a full third dose of the Moderna vaccine, but is now ready to move forward and consider the half-dose booster Moderna has proposed, the people said.
Biden, who got his Pfizer booster on Monday, has said this remains a pandemic of the unvaccinated.
Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, has said he believes Pfizer and Moderna will eventually be considered three-dose vaccines.
As the vaccination campaign widens, sites that administer them will have to juggle different versions. In addition to Moderna potentially adding a half-dose booster, Pfizer is seeking authorization of a vaccine for children ages 5 to 11, with a 10-microgram dose -- one-third the strength given to those 12 and up.
Fauci has indicated that there’ll be progress soon on booster shots for Moderna as well as Johnson & Johnson’s one-dose vaccine. “I believe it will be weeks and not months, he told NBC’s “Meet the Press earlier this month.
Moderna COVID-19 vaccine protection lasts longer than Pfizer, J&J over time: ReportThe effectiveness of the Moderna COVID-19 vaccine remains strong, new research suggests. The US Centers for Disease Control and Prevention (CDC) ... Coronavirus
Moderna says coronavirus vaccine protection declines, makes case for boosterNew data from Moderna Inc's large COVID-19 vaccine trial shows that the protection it offers declines over time, supporting the case for booster doses ... Coronavirus
Moderna working on booster to combine COVID-19 vaccine with a flu shotModerna said on Thursday it is developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot.The company ... Coronavirus